Corrigendum to’Endometrial membrane organoids from human embryonic stem cell combined with the 3D Matrigel for endometrium regeneration in asherman syndrome’[Bioactive Mater.6(2021)3935-3946]  

出　　处：《Bioactive Materials》2021年第12期4591-4591,共1页生物活性材料（英文）

摘　　要：Xiuxiu Jiang a,Xingmiao Li a,Xiangwei Fei b,Jiajie Shen b,Jianhua Chen c,Meijun Guo a,Yangyang Li b,*a Department of Gynecology,Women’s Hospital,Zhejiang University School of Medicine,Hangzhou City,Zhejiang Province,310006,China b Key Laboratory of Women′s Reproductive Health Research of Zhejiang Province,Women’s Hospital,Zhejiang University School of Medicine,Hangzhou City,Zhejiang Province,310006,China c Department of Pathology,Women’s Hospital,Zhejiang University School of Medicine,Hangzhou City,Zhejiang Province,310006,China The authors regret the incorrect publication of Fig.3A,which was not identified during the proofing stage.The corrected figure follows.The authors would like to apologise for any inconvenience caused.Fig.3.(A)Immunocharacterization of EEPC purity was analysed using flow cytometry by checking the expression of endoderm epithelial surface markers CXCR4(CD184)and E-cadherin(CD324)without sorting.

关 键 词：FIGURE corrected COR 

分 类 号：R318-5[医药卫生—生物医学工程]